AU8163394A - Treatment of diabetes by administration of myo-inositol - Google Patents

Treatment of diabetes by administration of myo-inositol

Info

Publication number
AU8163394A
AU8163394A AU81633/94A AU8163394A AU8163394A AU 8163394 A AU8163394 A AU 8163394A AU 81633/94 A AU81633/94 A AU 81633/94A AU 8163394 A AU8163394 A AU 8163394A AU 8163394 A AU8163394 A AU 8163394A
Authority
AU
Australia
Prior art keywords
myo
inositol
diabetes
administration
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81633/94A
Other languages
English (en)
Inventor
Harry L. Greene
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU8163394A publication Critical patent/AU8163394A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/37—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/801—Peptide sweetners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU81633/94A 1993-12-22 1994-12-21 Treatment of diabetes by administration of myo-inositol Abandoned AU8163394A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17381493A 1993-12-22 1993-12-22
US173814 1993-12-22

Publications (1)

Publication Number Publication Date
AU8163394A true AU8163394A (en) 1995-06-29

Family

ID=22633617

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81633/94A Abandoned AU8163394A (en) 1993-12-22 1994-12-21 Treatment of diabetes by administration of myo-inositol

Country Status (6)

Country Link
US (1) US5763392A (OSRAM)
EP (1) EP0659349A1 (OSRAM)
JP (1) JPH07223939A (OSRAM)
AU (1) AU8163394A (OSRAM)
CA (1) CA2137431A1 (OSRAM)
TW (1) TW282398B (OSRAM)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601395D0 (sv) * 1996-04-12 1996-04-12 Dieter Haeussinger New therapeutic treatment 1
NO962728A (no) * 1996-06-27 1997-11-17 Jan Oxholm Gordeladze Energidrikk
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
CA2284738C (en) * 1997-03-27 2008-12-23 Michael J. Sole Nutritional composition for improvements in cell energetics
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
CA2334222C (en) * 1998-06-05 2010-02-09 Technion Research And Development Foundation Ltd. Insulin supplemented infant formula
JP2002542295A (ja) * 1999-04-27 2002-12-10 インスメッド ファーマシューティカルズ， インコーポレイテッド 哺乳動物において、インスリン感受性およびグルコース代謝を改善する組成物および方法
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US20040110693A1 (en) * 2001-03-02 2004-06-10 Friedrich Trepel Agent for treating diabetes mellitus
US20040097467A1 (en) 2002-08-22 2004-05-20 Vijaya Juturu Arginine silicate inositol complex and use thereof
JP2004203863A (ja) * 2002-12-09 2004-07-22 Taisho Pharmaceut Co Ltd 抗糖尿病用組成物
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
CA2545584C (en) 2003-11-17 2012-10-23 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of metabolic disorders
AU2005306686B2 (en) * 2004-11-17 2011-06-02 Biomarin Pharmaceutical Inc. Stable tablet formulation of tetrahydrobiopterin
JP2006213684A (ja) * 2005-02-07 2006-08-17 Hokko Chem Ind Co Ltd インスリン抵抗性改善に用いられる組成物及び健康用食品
JP2007051132A (ja) * 2005-07-19 2007-03-01 Hokkaido Sugar Co Ltd イノシトールを成分とする食用組成物または医薬組成物
US7763650B2 (en) * 2006-03-15 2010-07-27 Medipharma S.A. Pharmaceutical compound and method
MX2010000660A (es) * 2009-12-11 2011-06-14 Abbott Lab Soluciones de rehidratacion oral que comprenden dextrosa.
ITMI20110445A1 (it) * 2011-03-22 2012-09-23 Lo Li Pharma Srl Formulazione farmaceutica comprendente inositolo.
TWI582110B (zh) * 2011-07-01 2017-05-11 Shiseido Co Ltd Platelet-derived growth factor-BB produces hyperactivity agents, and is associated with leaf-derived stem cell-producing accelerators, stem cell stabilizers, and dermal regenerators
ES2604110T3 (es) 2011-07-01 2017-03-03 Shiseido Company, Ltd. Activador de la producción del factor de crecimiento derivado de plaquetas-BB, y activador de la producción de células madre mesenquimatosas, estabilizador de células madre y regenerador de la dermis comprendiendo cada uno el mismo
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
CN106659739B (zh) 2014-08-08 2021-06-18 雀巢产品有限公司 维生素d和锌的组合产品及其用途
EP3177278A1 (en) 2014-08-08 2017-06-14 Nestec S.A. Vitamin b2 and its use
MX374378B (es) * 2014-08-08 2025-03-06 Soc Des Produits Nestle S A Star Mioinositol y probioticos, y uso de estos.
ES2792865T3 (es) * 2014-08-08 2020-11-12 Nestle Sa Mioinositol y probióticos y usos
CA2953030C (en) * 2014-08-08 2023-10-10 Nestec S.A. Myo-inositol and one or more probiotic and use thereof
US11191735B2 (en) 2015-03-13 2021-12-07 Nutrition 21, Llc Arginine silicate for periodontal disease
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
GB2568849B (en) 2016-09-01 2022-08-10 Nutrition 21 Llc Magnesium biotinate compositions and methods of use
US11898184B2 (en) * 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
CA3118583C (en) 2018-11-02 2024-05-14 Nutrition 21, Llc Compositions containing inositol-stabilized arginine silicate complexes and inositol for improving cognitive function in video gamers
EP4076413A1 (en) 2019-12-16 2022-10-26 Nutrition 21, LLC Methods of production of arginine-silicate complexes
CN111772022A (zh) * 2020-05-25 2020-10-16 唐传生物科技（厦门）有限公司 一种低gi健康糖及其制备方法和用途
WO2021259938A1 (en) * 2020-06-22 2021-12-30 Société des Produits Nestlé S.A. Compositions comprising myo-inositol and their use in the prevention of post partum haemorrhage (pph)
MX2023002627A (es) 2020-09-04 2023-03-17 Nestle Sa Composiciones y metodos para proporcionar beneficios de salud en un animal.
WO2023183767A1 (en) * 2022-03-21 2023-09-28 Abbott Laboratories Methods and compositions for increasing insulin sensitivity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497800A (en) * 1982-07-06 1985-02-05 Mead Johnson & Company Stable liquid diet composition
US4921877A (en) * 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
CA2047686C (en) * 1989-03-08 2000-09-05 Joseph Larner Dietary supplement for insulin-resistant diabetics
WO1991014435A1 (en) * 1990-03-19 1991-10-03 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes

Also Published As

Publication number Publication date
US5763392A (en) 1998-06-09
TW282398B (OSRAM) 1996-08-01
CA2137431A1 (en) 1995-06-23
EP0659349A1 (en) 1995-06-28
JPH07223939A (ja) 1995-08-22

Similar Documents

Publication Publication Date Title
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
AU7567394A (en) Treatment chamber catheter
AU3888793A (en) Novel medicament
EP0755690A3 (en) Hypodermic cannula
AU4000293A (en) Ophthalmologic cannula
AU6623894A (en) Therapeutic compounds
AU7867994A (en) Hemofiltration of mediator-related diseases
AU3560495A (en) Medicament inhaler
AU5160796A (en) Dual action syringe
AU5383390A (en) Laparoscopy cannula
AU4941193A (en) Medical pump assembly
AU8723191A (en) Steerable medical device
AU7338791A (en) Medical valve
AU8893291A (en) Medical electrode assembly
AU1774092A (en) Self destruct double syringe
AU6425496A (en) Treatment for juvenile diabetes
AU3236895A (en) Aspb1 insulin analogs
AU5965696A (en) Terpenoid-type quinones for treatment of diabetes
AU2954692A (en) Medical preparations
AU3950193A (en) Cannula
AU1111492A (en) Method of treating type i diabetes
AU1111592A (en) Method of treating type i diabetes
AU4219793A (en) Syringe
AU7644194A (en) Diagnosis of insulin-dependent diabetes
AU3730093A (en) Methods of treating diabetes